Most bought healthcare stocks in Q4 2016
See which Healthcare stocks institutional investors increased the most in Q4 2016, measured as net growth in reported share positions from Q3 2016 into Q4 2016. Notable additions at the top of this list include BRISTOL-MYERS SQUIBB CO (BMY), SANOFI-ADR (SNY), WALGREENS BOOTS ALLIANCE INC (WBA), CENCORA INC (COR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 18,785,314 | $1.12B | 1 | 4 | 4 | 0 | 12 |
| SNY | SANOFI-ADR | 9,225,910 | $516.92M | 0 | 1 | 3 | 0 | 6 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 8,592,572 | $725.65M | 1 | 3 | 3 | 1 | 9 |
| COR | CENCORA INC | 6,073,946 | $470.48M | 3 | 2 | 0 | 0 | 5 |
| CAH | CARDINAL HEALTH INC | 5,458,860 | $388.66M | 4 | 2 | 0 | 2 | 7 |
| GILD | GILEAD SCIENCES INC | 5,057,597 | $237.78M | 0 | 7 | 5 | 0 | 13 |
| CVS | CVS HEALTH CORP | 4,526,145 | $269.26M | 3 | 5 | 4 | 0 | 12 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 4,052,612 | -$8.35M | 1 | 1 | 0 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | 3,793,150 | $595.42M | 3 | 2 | 3 | 0 | 10 |
| PRGO | Perrigo Company PLC | 3,322,447 | $257.94M | 1 | 2 | 0 | 0 | 4 |
| MCK | MCKESSON CORP | 2,404,328 | $241.51M | 3 | 4 | 0 | 3 | 7 |
| CNC | CENTENE CORP | 2,078,696 | $108.93M | 2 | 1 | 0 | 0 | 3 |
| NVS | NOVARTIS AG-SPONSORED ADR | 1,955,924 | -$170.11M | 0 | 3 | 5 | 0 | 9 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 1,809,757 | -$239.15M | 0 | 1 | 2 | 0 | 4 |
| ELV | ELEVANCE HEALTH INC | 1,698,150 | $457.03M | 1 | 3 | 4 | 0 | 9 |
| HUM | HUMANA INC | 1,643,912 | $415.59M | 0 | 3 | 0 | 0 | 3 |
| ALGN | ALIGN TECHNOLOGY INC | 1,599,251 | $168.55M | 1 | 4 | 0 | 0 | 5 |
| JNJ | JOHNSON & JOHNSON | 1,582,783 | $119.48M | 0 | 9 | 11 | 0 | 22 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 1,573,087 | $6.56M | 1 | 0 | 1 | 0 | 2 |
| A | AGILENT TECHNOLOGIES INC | 1,556,246 | $59.87M | 0 | 3 | 0 | 1 | 4 |
| XRAY | DENTSPLY SIRONA INC | 1,391,420 | $77.70M | 0 | 3 | 1 | 0 | 4 |
| THC | TENET HEALTHCARE CORP | 1,325,875 | $19.68M | 1 | 0 | 0 | 0 | 1 |
| BSX | BOSTON SCIENTIFIC CORP | 1,280,659 | $22.71M | 1 | 1 | 2 | 0 | 4 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,004,030 | $76.54M | 2 | 2 | 0 | 0 | 4 |
| SYK | STRYKER CORP | 985,813 | $146.06M | 0 | 2 | 2 | 0 | 4 |
| ACHC | ACADIA HEALTHCARE CO INC | 970,500 | $32.12M | 1 | 0 | 0 | 0 | 1 |
| HOLX | HOLOGIC INC | 833,490 | $36.03M | 0 | 1 | 2 | 0 | 3 |
| CORT | CORCEPT THERAPEUTICS INC | 822,500 | $6.49M | 0 | 1 | 0 | 1 | 1 |
| REGN | REGENERON PHARMACEUTICALS | 781,230 | $258.44M | 3 | 1 | 0 | 0 | 4 |
| CERS | CERUS CORP | 743,815 | $3.24M | 2 | 0 | 0 | 0 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | 653,161 | -$11.10M | 2 | 2 | 3 | 0 | 10 |
| CARA | CARA THERAPEUTICS INC | 640,225 | $6.18M | 1 | 0 | 0 | 1 | 1 |
| MCRB | SERES THERAPEUTICS INC | 595,864 | $5.19M | 1 | 1 | 0 | 0 | 2 |
| ILMN | ILLUMINA INC | 506,078 | $64.78M | 2 | 0 | 0 | 0 | 3 |
| WAT | WATERS CORP | 493,275 | -$44.78M | 0 | 4 | 0 | 0 | 4 |
| HSIC | HENRY SCHEIN INC | 485,702 | $73.67M | 2 | 0 | 0 | 0 | 3 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 463,951 | $1.83M | 1 | 0 | 0 | 0 | 1 |
| OMI | OWENS & MINOR INC | 387,190 | $14.19M | 0 | 1 | 0 | 0 | 1 |
| CRL | CHARLES RIVER LABORATORIES | 384,724 | $11.81M | 0 | 3 | 0 | 0 | 3 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 338,166 | -$1.69M | 0 | 1 | 0 | 0 | 1 |
| AMRN | AMARIN CORP PLC -ADR | 335,400 | $1.03M | 0 | 1 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 288,500 | -$27.64M | 0 | 4 | 1 | 3 | 8 |
| HALO | HALOZYME THERAPEUTICS INC | 266,834 | -$13.85M | 1 | 1 | 1 | 0 | 3 |
| LNTH | LANTHEUS HOLDINGS INC | 238,900 | $2.10M | 0 | 1 | 0 | 0 | 1 |
| OSUR | ORASURE TECHNOLOGIES INC | 225,800 | $5.20M | 0 | 1 | 0 | 0 | 1 |
| TFX | TELEFLEX INC | 192,505 | $29.71M | 0 | 1 | 1 | 1 | 2 |
| IONS | IONIS PHARMACEUTICALS INC | 181,321 | $11.75M | 1 | 1 | 0 | 0 | 2 |
| ACRS | ACLARIS THERAPEUTICS INC | 174,600 | $4.74M | 1 | 0 | 0 | 0 | 1 |
| INCY | INCYTE CORP | 164,602 | $20.98M | 1 | 1 | 1 | 1 | 3 |
| OCUL | OCULAR THERAPEUTIX INC | 145,100 | $1.21M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q4 2016
What are the most bought Healthcare stocks in Q4 2016?
The most bought healthcare stocks in Q4 2016 are those with the largest increase in reported share counts across institutional investors compared to Q3 2016, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2016?
Among filers in this sector, net additions were largest in companies such as BRISTOL-MYERS SQUIBB CO (BMY), SANOFI-ADR (SNY), WALGREENS BOOTS ALLIANCE INC (WBA), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2016).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.